Skip to main content
VCbacked
Log inGet Started

Aspen Neuroscience

San Diego, United States

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

$115.0M raised
Nov 2025
Series C
BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Top Investors

GaingelsOrbiMedARCH Venture PartnersCormorant Asset ManagementS32

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aspen Neuroscience

How much funding has Aspen Neuroscience raised?
Aspen Neuroscience has raised $115.0M in total funding. The most recent round was Series C. The last funding was announced in November 2025.
Who are Aspen Neuroscience's investors?
Aspen Neuroscience's investors include Gaingels, OrbiMed, ARCH Venture Partners, Cormorant Asset Management, S32.
Where is Aspen Neuroscience headquartered?
Aspen Neuroscience is headquartered in San Diego, United States.
What does Aspen Neuroscience do?
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
What stage is Aspen Neuroscience at?
Aspen Neuroscience is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aspen Neuroscience — Funding & Investors." VCBacked, November 20, 2025, https://www.vcbacked.co/company/aspen-neuroscience. Accessed June 3, 2026.
APA
VCBacked. (2025). Aspen Neuroscience — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/aspen-neuroscience
Wikipedia (cite web)
{{cite web |title=Aspen Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/aspen-neuroscience |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong